Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Bio-Techne Corp TECH

Healthcare  —  Biotechnology
72.61 0.04 0.06% as of 25 Sep
Market cap
$11.4B
P/E
62.1×
S&P 500 Member Dividend Champion (3y)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Bio-Techne Corp (TECH) EV/Sales

As of 25 September 2026, Bio-Techne Corp (TECH) trades at a EV/Sales of 9.3×. Over the past ten years it has ranged from 5.6× (May 2026) to 22.5× (September 2021); the current reading is higher than 44% of that period. That is below the Biotechnology industry median of 10.7× and above the Healthcare sector median of 3.6×.

EV/Sales, daily

Annual

Period EV/Sales Change
FY2026 9.0× 32.62%
FY2025 6.8× (31.24%)
FY2024 9.9× (13.37%)
FY2023 11.4× (7.14%)
FY2022 12.3× (34.75%)
FY2021 18.9× 36.91%
FY2020 13.8× 19.26%
FY2019 11.5× 29.99%
FY2018 8.9× 9.43%
FY2017 8.1× (3.29%)

Quarterly

Period EV/Sales Change
Jun 2026 9.0× 33.73%
Mar 2026 6.7× (11.44%)
Dec 2025 7.6× 5.19%
Sep 2025 7.2× 6.46%
42 more quarters

Against its own ten years

Low 5.6× High 22.5×
Ten-year median 9.8×
Current reading's percentile 44

EV/Sales against peers

Company EV/Sales
BMRN BioMarin Pharmaceutical Inc. compare 4.4×
HALO Halozyme Therapeutics, Inc. compare 9.2×
TECH Bio-Techne Corp 9.3×
MDGL Madrigal Pharmaceuticals, Inc. compare 11.3×
AXSM Axsome Therapeutics, Inc. compare 12.8×
CORT Corcept Therapeutics Incorporated compare 14.4×
BBIO BridgeBio Pharma, Inc. compare 19.7×
KRYS Krystal Biotech, Inc. compare 21.3×
SMMT Summit Therapeutics PLC compare 16,392×
Biotechnology industry median 10.7×
Healthcare sector median 3.6×
Market median 2.2×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on TECH